Hideyuki Shiba

515 total citations
27 papers, 332 citations indexed

About

Hideyuki Shiba is a scholar working on Rheumatology, Pulmonary and Respiratory Medicine and Epidemiology. According to data from OpenAlex, Hideyuki Shiba has authored 27 papers receiving a total of 332 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Rheumatology, 10 papers in Pulmonary and Respiratory Medicine and 7 papers in Epidemiology. Recurrent topics in Hideyuki Shiba's work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (8 papers), Vasculitis and related conditions (5 papers) and Inflammatory Myopathies and Dermatomyositis (5 papers). Hideyuki Shiba is often cited by papers focused on Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (8 papers), Vasculitis and related conditions (5 papers) and Inflammatory Myopathies and Dermatomyositis (5 papers). Hideyuki Shiba collaborates with scholars based in Japan and United States. Hideyuki Shiba's co-authors include Takanori Shibata, Tohru Takeuchi, Takuya Kotani, Tadaki Nakahara, Hiromasa Kawana, Kenichiro Hata, Youhei Fujiki, Takeshi Shoda, Shigeki Makino and Koji Nagai and has published in prestigious journals such as Scientific Reports, International Journal of Molecular Sciences and Annals of the Rheumatic Diseases.

In The Last Decade

Hideyuki Shiba

27 papers receiving 276 citations

Peers

Countries citing papers authored by Hideyuki Shiba

Since Specialization

Citations

This map shows the geographic impact of Hideyuki Shiba's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hideyuki Shiba with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hideyuki Shiba more than expected).

Fields of papers citing papers by Hideyuki Shiba

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hideyuki Shiba. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hideyuki Shiba. The network helps show where Hideyuki Shiba may publish in the future.

Co-authorship network of co-authors of Hideyuki Shiba

This figure shows the co-authorship network connecting the top 25 collaborators of Hideyuki Shiba. A scholar is included among the top collaborators of Hideyuki Shiba based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hideyuki Shiba. Hideyuki Shiba is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Aggressive multi‐combination therapy for anti‐MDA5 antibody‐positive dermatomyositis‐rapidly progressive interstitial lung disease 2023 ·International Journal of Rheumatic Diseases ·Kenichiro Hata, Takuya Kotani, (unknown), Youhei Fujiki, (unknown), (unknown), Yumiko Wada, Hideyuki Shiba, Takeshi Shoda, (unknown), Tohru Takeuchi	3
2	IL-6 inhibitors and JAK inhibitors as favourable treatment options for patients with anaemia and rheumatoid arthritis: ANSWER cohort study 2023 ·Lara D. Veeken ·Yoichi Nakayama, Ryu Watanabe, Wataru Yamamoto, Kosuke Ebina, Tôru Hirano, Takuya Kotani, Hideyuki Shiba, Masaki Katayama, Yonsu Son, Hideki Amuro, Akira Ōnishi, Sadao Jinno, Ryota Hara, Kosaku Murakami, Koichi Murata, Hiromu Ito, Masao Tanaka, Shuichi Matsuda, Akio Morinobu, Motomu Hashimoto	5
3	Prognostic Factors Affecting Death in Patients with Rheumatoid Arthritis Complicated by Pneumocystis jirovecii Pneumonia and One-Year Clinical Course: The ANSWER Cohort Study 2023 ·International Journal of Molecular Sciences ·Hideyuki Shiba, Takuya Kotani, Koji Nagai, (unknown), Wataru Yamamoto, (unknown), Yumiko Wada, (unknown), (unknown), Yo Ueda, Akira Ōnishi, Koichi Murata, Hideki Amuro, Yonsu Son, Ryota Hara, Tôru Hirano, Kosuke Ebina, Masaki Katayama, Motomu Hashimoto, Tohru Takeuchi	4
4	AB0407 IMPACT OF SEROPOSITIVITY ON DRUG RETENTION OF BIOLOGICS AND JAK INHIBITORS -THE ANSWER COHORT STUDY 2023 ·Annals of the Rheumatic Diseases ·Yuki Etani, Kosuke Ebina, Yasutaka Okita, Yuichi Maeda, (unknown), Akira Ōnishi, (unknown), T. Okano, Kunihiro Nishimura, (unknown), Hideyuki Shiba, Hideki Amuro, Yonsu Son, (unknown), Ryota Hara, Wataru Yamamoto, Atsushi Kumanogoh, Seiji Okada	1
5	Serum Complement C4 Levels Are a Useful Biomarker for Predicting End-Stage Renal Disease in Microscopic Polyangiitis 2023 ·International Journal of Molecular Sciences ·(unknown), (unknown), Takuya Kotani, (unknown), (unknown), (unknown), Yumiko Wada, Hideyuki Shiba, Kenichiro Hata, Takeshi Shoda, Tohru Takeuchi	7
6	Association of M2 Macrophages, Th2, and B Cells With Pathomechanism in Microscopic Polyangiitis Complicated by Interstitial Lung Disease 2022 ·The Journal of Rheumatology ·(unknown), Takuya Kotani, Hiroko Kuwabara, (unknown), (unknown), (unknown), Takaaki Ishida, Youhei Fujiki, Hideyuki Shiba, Kenichiro Hata, Takeshi Shoda, Yoshinobu Hirose, Tohru Takeuchi	6
7	Examination of nailfold videocapillaroscopy findings in ANCA-associated vasculitis 2022 ·Lara D. Veeken ·(unknown), Takuya Kotani, (unknown), (unknown), Hiroko Kuwabara, (unknown), (unknown), Hideyuki Shiba, Kenichiro Hata, Takeshi Shoda, Yoshinobu Hirose, Tohru Takeuchi	8
8	Prognostic factors affecting respiratory-related death in patients with rheumatoid arthritis complicated by interstitial lung disease: An ANSWER cohort study 2022 ·Modern Rheumatology ·(unknown), Takuya Kotani, (unknown), Daisuke Nishioka, Wataru Yamamoto, (unknown), Yumiko Wada, (unknown), Hideyuki Shiba, Koji Nagai, (unknown), (unknown), Hideki Amuro, Akira Ōnishi, (unknown), Ryota Hara, Tôru Hirano, Motomu Hashimoto, Tohru Takeuchi	4
9	The use of SPECT/CT to assess resorptive activity in mandibular condyles 2021 ·International Journal of Oral and Maxillofacial Surgery ·K Munakata, (unknown), Tadaki Nakahara, Hideyuki Shiba, Keisuke Sugahara, Akira Katakura, Taneaki Nakagawa	8
10	Evaluation of poor prognostic factors of respiratory related death in microscopic polyangiitis complicated by interstitial lung disease 2021 ·Scientific Reports ·(unknown), Takuya Kotani, (unknown), (unknown), Keisuke Fukui, (unknown), Takaaki Ishida, Youhei Fujiki, Hideyuki Shiba, Koji Nagai, Kenichiro Hata, Takeshi Shoda, Yuri Ito, Shigeki Makino, Tohru Takeuchi	18
11	CCL2 produced by CD68+/CD163+ macrophages as a promising clinical biomarker of microscopic polyangiitis-interstitial lung disease 2021 ·Lara D. Veeken ·(unknown), Takuya Kotani, Hiroko Kuwabara, (unknown), (unknown), Keisuke Fukui, Takaaki Ishida, Youhei Fujiki, Hideyuki Shiba, Kenichiro Hata, Takeshi Shoda, Yoshinobu Hirose, Tohru Takeuchi	24
12	Drug retention of 7 biologics and tofacitinib in biologics-naïve and biologics-switched patients with rheumatoid arthritis: the ANSWER cohort study 2020 ·Arthritis Research & Therapy ·Kosuke Ebina, Tôru Hirano, Yuichi Maeda, Wataru Yamamoto, Motomu Hashimoto, Koichi Murata, Tohru Takeuchi, Hideyuki Shiba, Yonsu Son, Hideki Amuro, Akira Ōnishi, Kengo Akashi, Ryota Hara, Masaki Katayama, Keiichi Yamamoto, Atsushi Kumanogoh, Makoto Hirao	28
13	Clinical value of 3D SPECT/CT imaging for assessing jaw bone invasion in oral cancer patients 2019 ·Journal of Cranio-Maxillofacial Surgery ·(unknown), Tadaki Nakahara, Seiji Asoda, Kaori Kameyama, Miho Kawaida, (unknown), Hideyuki Shiba, Masahiro Jinzaki, Hiromasa Kawana, Taneaki Nakagawa	5
14	Clinical utility of three-dimensional SPECT/CT imaging as a guide for the resection of medication-related osteonecrosis of the jaw 2015 ·International Journal of Oral and Maxillofacial Surgery ·(unknown), Hideyuki Shiba, Hiromasa Kawana, Tadaki Nakahara	29
15	Lung <i>Nocardia elegans</i> Infection Diagnosed on Matrix-assisted Laser Desorption Ionization-time of Flight Mass Spectrometry (MALDI-TOF MS) 2014 ·Internal Medicine ·(unknown), Hideyuki Shiba, Koji Nagai, (unknown), Toyofumi Nakanishi, Takashi Nakano, Akira Ukimura, Tohru Gonoi	8
16	Dermatomyositis as a complication of interferon-α therapy: a case report and review of the literature 2014 ·Rheumatology International ·Hideyuki Shiba, Tohru Takeuchi, Kentaro Isoda, (unknown), Yumiko Wada, Shigeki Makino, Toshiaki Hanafusa	9
17	Therapeutic drug monitoring of cyclosporine microemulsion in interstitial pneumonia with dermatomyositis 2011 ·Modern Rheumatology ·Koji Nagai, Tohru Takeuchi, Takuya Kotani, Kenichiro Hata, Shuzo Yoshida, Kentaro Isoda, Youhei Fujiki, Hideyuki Shiba, Shigeki Makino, Toshiaki Hanafusa	12
18	Therapeutic drug monitoring of cyclosporine microemulsion in interstitial pneumonia with dermatomyositis 2010 ·Modern Rheumatology ·Koji Nagai, Tohru Takeuchi, Takuya Kotani, Kenichiro Hata, Shuzo Yoshida, Kentaro Isoda, Youhei Fujiki, Hideyuki Shiba, Shigeki Makino, Toshiaki Hanafusa	12
19	The reproducibility of a HeadFix relocatable fixation system: analysis using the stereotactic coordinates of bilateral incus and the top of the crista galli obtained from a serial CT scan 2009 ·Physics in Medicine and Biology ·Etsuo Kunieda, Yohei Oku, Junichi Fukada, Osamu Kawaguchi, Hideyuki Shiba, Atsuya Takeda, Atsushi Kubo	5
20	Adenocarcinoma of the sublingual gland. 1991 ·The Keio Journal of Medicine ·(unknown), (unknown), Hideyuki Shiba, Yutaka Okada, (unknown)	3

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact